BrightSpring Health Services, Inc. BTSG
56.59
0.57
1.02%
as of 25 Sep
- Market cap
- $11.1B
- P/E
- 31.6×
Follow BTSG
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | |
|---|---|---|---|---|---|
P/E ratio |
39.84 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.59 | 0.33 | 0.15 | 0.15 | 0.15 |
P/FCF ratio |
19.22 | 0.00 | 9.45 | 9.45 | 9.45 |
P/Operating CF |
32.76 | 36.27 | 7.98 | 7.98 | 7.98 |
P/B ratio |
4.05 | 1.99 | 2.21 | 2.21 | 2.21 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.78 | 0.58 | 0.53 | 0.53 | 0.53 |
EV/EBITDA |
21.28 | 18.00 | 3.30 | 3.30 | 3.30 |
EV/Operating CF |
20.44 | 245.77 | 22.16 | 22.16 | 22.16 |
EV/FCF |
25.39 | (102.26) | 34.02 | 34.02 | 34.02 |
Quick Ratio |
0.58 | 0.67 | 0.72 | 0.85 | — |
Current Ratio |
1.57 | 1.33 | 1.17 | 1.44 | — |
Net Debt/EBITDA |
5.17 | 7.88 | 11.99 | 7.51 | 0.00 |
Debt/Assets |
39.33% | 44.16% | 61.21% | 62.76% | 0.00% |
Debt/Equity |
1.35 | 1.59 | 5.79 | 4.52 | 0.00 |
Asset Turnover |
2.09 | 1.76 | 1.40 | 2.84 | 0.00 |
Operating CF/Net income |
2.57 | (1.32) | (1.36) | 0.09 | 5.43 |
Capex/Depreciation |
(0.54) | (0.37) | (0.33) | (0.26) | (0.27) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 10.82% | (1.62%) | (23.07%) | 0.00% | 0.00% | |
| 3.09% | (0.32%) | (2.82%) | (1.98%) | 0.00% | |
ROIC |
4.28% | 1.60% | 0.92% | 2.82% | 0.00% |
Return on Tangible Assets |
15.26% | (2.80%) | (34.05%) | (8.41%) | 0.00% |
Average Days of Receivables |
27.98 | 32.72 | 41.84 | 36.68 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
9.47% | 11.50% | 14.05% | 14.58% | 15.14% |
Intangible Assets out of Total Assets |
0.48 | 0.50 | 0.63 | 0.65 | 0.00 |
Share Based Compensation of Revenue |
0.54% | 0.69% | 0.05% | 0.05% | 0.07% |
Graham Net Nets |
(0.22) | (0.73) | (2.69) | (2.69) | (2.69) |
Graham Number |
13.99 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
2.51% | (0.70%) | (12.09%) | (12.09%) | (12.09%) |
Free Cash Flow Yield |
5.20% | (1.74%) | 10.59% | 10.59% | 10.59% |
Revenue per Share |
63.74 | 52.19 | 65.25 | 65.52 | 56.96 |
Operating CF per Share |
2.42 | 0.12 | 1.79 | (0.04) | 2.30 |
Capex per Share |
(0.47) | (0.42) | (0.62) | (0.59) | (0.50) |
Free Cash Flow per Share |
1.95 | (0.30) | 1.16 | (0.63) | 1.79 |
Cash per Share |
0.44 | 0.32 | 0.11 | 0.12 | 0.00 |
Shareholders Equity per Share |
9.26 | 8.54 | 4.97 | 6.41 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
9.26 | 8.54 | 4.97 | 6.41 | 0.00 |
Free Cash Flow |
394.69 | (57.14) | 137.26 | (74.77) | 210.90 |
Working Capital |
1,045.02 | 464.72 | 208.20 | 411.75 | — |
Capital Expenditures |
(95.48) | (80.91) | (73.53) | (70.11) | (59.27) |
Net Current Asset Value |
(1,644.12) | (2,385.23) | (3,490.67) | (3,342.11) | 0.00 |
EV/EBIT |
33.94 | 54.12 | 3.91 | 3.91 | 3.91 |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Net Profit Margin |
1.48% | (0.18%) | (2.01%) | (0.70%) | 0.74% |
Price to Operating Income |
25.69 | 30.45 | 1.09 | 1.09 | 1.09 |
| Other line items | |||||
Depreciation/Fixed assets |
0.86 | 1.20 | 0.91 | 1.16 | 0.00 |
Cash ROIC |
6.36% | (3.62%) | (0.88%) | (5.59%) | 0.00% |
Accounts Receivable Turnover |
13.64 | 11.29 | 9.28 | 0.00 | 0.00 |
Accounts Payable Turnover |
10.64 | 11.25 | 11.21 | 0.00 | 0.00 |
Inventory Turnover |
15.70 | 16.95 | 15.73 | 0.00 | 0.00 |
Average Days of Payables |
39.02 | 38.30 | 35.74 | 30.21 | 0.00 |
Days of Inventory on Hand |
26.12 | 26.39 | 22.44 | 24.68 | 0.00 |
Average Receivables |
946.25 | 892.20 | 828.74 | — | — |
Average Payables |
1,070.94 | 782.77 | 584.26 | — | — |
Average Inventory |
725.87 | 519.67 | 416.65 | — | — |
Average Assets |
6,169.73 | 5,729.43 | 5,486.93 | 2,720.57 | — |
Average Common Equity |
1,761.50 | 1,116.63 | 670.09 | — | — |
Columns are period end dates